Tomoo Kobayashi

765 total citations
23 papers, 253 citations indexed

About

Tomoo Kobayashi is a scholar working on Epidemiology, Hepatology and Immunology. According to data from OpenAlex, Tomoo Kobayashi has authored 23 papers receiving a total of 253 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Epidemiology, 19 papers in Hepatology and 3 papers in Immunology. Recurrent topics in Tomoo Kobayashi's work include Hepatitis B Virus Studies (18 papers), Hepatitis C virus research (16 papers) and Liver Disease Diagnosis and Treatment (15 papers). Tomoo Kobayashi is often cited by papers focused on Hepatitis B Virus Studies (18 papers), Hepatitis C virus research (16 papers) and Liver Disease Diagnosis and Treatment (15 papers). Tomoo Kobayashi collaborates with scholars based in Japan, India and Greece. Tomoo Kobayashi's co-authors include Yoshiyuki Ueno, Tooru Shimosegawa, Yasuteru Kondo, Koju Kobayashi, Masaaki Shiina, Masashi Ninomiya, Eiji Kakazu, Jun Inoue, Masafumi Komatsu and Yasuji Komorizono and has published in prestigious journals such as PLoS ONE, The Journal of Infectious Diseases and Medicine.

In The Last Decade

Tomoo Kobayashi

20 papers receiving 247 citations

Peers

Tomoo Kobayashi
Carl Janssen Belgium
Ming‐Yen Hsieh Taiwan
Nico Buettner Germany
Rajneesh Kumar Singapore
Satoyoshi Yamashita Japan
Erica Nicola Lynch Italy
Chitomi Hasebe Japan
Moana Gelu‐Siméon France
Raffaella Francesconi Italy
Yanjie Ren Qatar
Carl Janssen Belgium
Tomoo Kobayashi
Citations per year, relative to Tomoo Kobayashi Tomoo Kobayashi (= 1×) peers Carl Janssen

Countries citing papers authored by Tomoo Kobayashi

Since Specialization
Citations

This map shows the geographic impact of Tomoo Kobayashi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomoo Kobayashi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomoo Kobayashi more than expected).

Fields of papers citing papers by Tomoo Kobayashi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomoo Kobayashi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomoo Kobayashi. The network helps show where Tomoo Kobayashi may publish in the future.

Co-authorship network of co-authors of Tomoo Kobayashi

This figure shows the co-authorship network connecting the top 25 collaborators of Tomoo Kobayashi. A scholar is included among the top collaborators of Tomoo Kobayashi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomoo Kobayashi. Tomoo Kobayashi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sato, Kosuke, Jun Inoue, Takehiro Akahane, et al.. (2025). Comparison of hepatitis B virus genotype B and C patients in Japan in terms of family history and maternal age at birth. Hepatology Research. 55(5). 773–779.
2.
3.
Inoue, Jun, Kazumichi Abe, Hiroaki Haga, et al.. (2025). Validation Study of Scores Predicting Hepatocellular Carcinoma Risk in Chronic Hepatitis B Patients Treated With Nucleos(t)ide Analogues. Journal of Viral Hepatitis. 32(4). e70021–e70021.
4.
Inoue, Jun, Takehiro Akahane, Tomoo Kobayashi, et al.. (2023). Usefulness of the Fibrosis‐4 index and alanine aminotransferase at 1 year of nucleos(t)ide analog treatment for prediction of hepatocellular carcinoma in chronic hepatitis B patients. Hepatology Research. 54(2). 131–141. 1 indexed citations
5.
6.
Sato, Kosuke, Jun Inoue, Takehiro Akahane, et al.. (2022). Switching to Tenofovir Alafenamide Fumarate in Chronic Hepatitis B Patients Who Had Detectable HBV DNA during Treatment with Entecavir. The Tohoku Journal of Experimental Medicine. 258(4). 277–285. 2 indexed citations
7.
Inoue, Jun, Takehiro Akahane, Tomoo Kobayashi, et al.. (2020). Switching to tenofovir disoproxil fumarate in entecavir‑treated chronic hepatitis B patients: A pilot randomized controlled study. Biomedical Reports. 14(2). 20–20. 5 indexed citations
8.
Inoue, Jun, Atsushi Kanno, Yuta Wakui, et al.. (2016). Identification of Genotype 2 HCV in Serotype-1 Hepatitis C Patients Unresponsive to Daclatasvir plus Asunaprevir Treatment. The Tohoku Journal of Experimental Medicine. 241(1). 21–28. 2 indexed citations
9.
Inoue, Jun, Yasuteru Kondo, Takeshi Yamamoto, et al.. (2015). Shifting hepatitis B virus genotypes of acute hepatitis B patients in northeast Japan. Journal of Medical Virology. 88(1). 69–78. 5 indexed citations
10.
Sakaida, Isao, Satoyoshi Yamashita, Tomoo Kobayashi, et al.. (2013). Efficacy and safety of a 14-day administration of tolvaptan in the treatment of patients with ascites in hepatic oedema. Journal of International Medical Research. 41(3). 835–847. 44 indexed citations
11.
Kondo, Yasuteru, Takanobu Kato, Osamu Kimura, et al.. (2013). 1(OH) Vitamin D3 Supplementation Improves the Sensitivity of the Immune-Response during Peg-IFN/RBV Therapy in Chronic Hepatitis C Patients-Case Controlled Trial. PLoS ONE. 8(5). e63672–e63672. 26 indexed citations
12.
Kondo, Yasuteru, Yoshiyuki Ueno, Masashi Ninomiya, et al.. (2012). Sequential immunological analysis of HBV/HCV co-infected patients during Peg-IFN/RBV therapy. Journal of Gastroenterology. 47(12). 1323–1335. 7 indexed citations
13.
Inoue, Jun, Yoshiyuki Ueno, Takeshi Yamamoto, et al.. (2012). Association between S21 substitution in the core protein of hepatitis B virus and fulminant hepatitis. Journal of Clinical Virology. 55(2). 147–152. 17 indexed citations
14.
Kondo, Yasuteru, Yoshiyuki Ueno, Koju Kobayashi, et al.. (2010). Hepatitis B Virus Replication Could Enhance Regulatory T Cell Activity by Producing Soluble Heat Shock Protein 60 From Hepatocytes. The Journal of Infectious Diseases. 202(2). 202–213. 39 indexed citations
15.
Kogure, Takayuki, Yoshiyuki Ueno, Koji Fukushima, et al.. (2008). Pegylated interferon plus ribavirin for genotype Ib chronic hepatitis C in Japan. World Journal of Gastroenterology. 14(47). 7225–7225. 15 indexed citations
16.
Shiina, Masaaki, Koju Kobayashi, Tomoo Kobayashi, et al.. (2006). Dynamics of immature subsets of dendritic cells during antiviral therapy in HLA-A24–positive chronic hepatitis C patients. Journal of Gastroenterology. 41(8). 758–764. 7 indexed citations
17.
Kondo, Yasuteru, Shinichi Asabe, Koju Kobayashi, et al.. (2004). Recovery of functional cytotoxic T lymphocytes during lamivudine therapy by acquiring multi‐specificity. Journal of Medical Virology. 74(3). 425–433. 28 indexed citations
18.
Kondo, Yasuteru, Koju Kobayashi, Tomoo Kobayashi, et al.. (2003). Distribution of the HLA Class I Allele in Chronic Hepatitis C and its Association with Serum ALT Level in Chronic Hepatitis C. The Tohoku Journal of Experimental Medicine. 201(2). 109–117. 16 indexed citations
19.
Suzuki, Chiaki, Tomoo Kobayashi, Yutaka Mano, et al.. (1999). An adult patient with acute hepatitis B virus (genotype A) infection who became a chronic carrier.. Kanzo. 40(6). 346–349. 6 indexed citations
20.
Miyake, Michihiro, Tomoo Kobayashi, & Takashi Suzuki. (1986). Structural Change of Synthetic Hydroxyapatite by Ion-Exchange Reaction. Journal of the Ceramic Association Japan. 94(1092). 832–836. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carl Janssen Breakdown of academic impact, for papers by Ming‐Yen Hsieh Breakdown of academic impact, for papers by Nico Buettner Breakdown of academic impact, for papers by Rajneesh Kumar Breakdown of academic impact, for papers by Satoyoshi Yamashita Breakdown of academic impact, for papers by Erica Nicola Lynch Breakdown of academic impact, for papers by Chitomi Hasebe Breakdown of academic impact, for papers by Moana Gelu‐Siméon Breakdown of academic impact, for papers by Raffaella Francesconi Breakdown of academic impact, for papers by Yanjie Ren
Rankless by CCL
2026